2002

Jul 18, 2002
FDA Approves Expanded Indication for Guidant Implantable Defibrillators

MADIT II-Based Indication Provides Lifesaving Technology to Thousands of At-Risk Heart Attack Survivors Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader...

Jul 18, 2002
Guidant Reports All-Time Record Sales and Earnings

Quarterly Sales reach $807 million (+23 percent) with adjusted Net Income of $163 million (+42 percent) and Earnings Per Share of $0.53 (+41 percent) Double-digit sales and earnings growth...

Jul 2, 2002
Patient Successfully Treated for Postoperative Atrial Fibrillation Using Guidant's SYNCRUS System

New Solution Offers Fast, Effective Treatment For Common Complication After Cardiac Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Jul 1, 2002
Guidant Announces Live Webcast of its Second Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2002 earnings...

Jul 1, 2002
Guidant Studies Use of Endoscopic Radial Artery Harvesting In Coronary Bypass Graft Surgery

Study Intended to Expand Indications for VASOVIEW Endoscopic Vessel Harvesting System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jun 24, 2002
Guidant to Participate in the William Blair & Co. 22nd Annual Growth Stock Conference

Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...

Jun 20, 2002
Guidant Supports MayoClinic.com in Heart Disease Education

Relationship Advances Efforts to Increase Patient Awareness of Disease and Therapies Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Jun 13, 2002
Guidant Reaffirms Commitment to Paclitaxel Eluting Stent Program

Guidant Comments on Summary Judgment Ruling in Cook-Boston Scientific Litigation Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported today that the United States District Court...

Jun 6, 2002
Guidant to Participate in the 23rd Annual Goldman Sachs Global Healthcare Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the 23rd Annual Goldman...

May 31, 2002
Guidant's Market-Leading MULTI-LINK PENTA Stent Demonstrates Excellent Clinical Data

Six Month Follow-Up Study Shows 17.5 Percent Binary Restenosis Rate Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

Show per page

Top